XOM
50
-3
AA
67
-5
SEE
56
3
EMC
60
-12
NRG
50
-10
CPB
39
2
BF.B
59
-2
CCI
42
-2
UHS
60
-3
MAT
45
-7
NTAP
60
-6
D
41
4
CHRW
73
-4
PG
43
3
ILMN
70
-4
NI
63
-4
DTE
38
-2
STI
11
-2
HAL
55
-5
HOG
35
-3
XOM
50
-3
AA
67
-5
SEE
56
3
EMC
60
-12
NRG
50
-10
CPB
39
2
BF.B
59
-2
CCI
42
-2
UHS
60
-3
MAT
45
-7
NTAP
60
-6
D
41
4
CHRW
73
-4
PG
43
3
ILMN
70
-4
NI
63
-4
DTE
38
-2
STI
11
-2
HAL
55
-5
HOG
35
-3
Financhill
Back

Parametric Equity Premium Income ETF Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison

Buy
68

PAPI
Parametric Equity Premium Income ETF

Last Price:
$26.24
Seasonality Move:
4.07%
Buy
67

RYTM
Rhythm Pharmaceuticals, Inc.

Last Price:
$113.50
Seasonality Move:
-9.01%
Buy
68
Parametric Equity Premium Income ETF (PAPI) is a Buy

Is Parametric Equity Premium Income ETF a Buy, Sell or Hold?

  • The current Parametric Equity Premium Income ETF [PAPI] share price is $26.26. The Score for PAPI is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
  • PAPI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Rhythm Pharmaceuticals, Inc. (RYTM) is a Buy

Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $113.56. The Score for RYTM is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PAPI Stock Price Chart

What is Parametric Equity Premium Income ETF's stock price today?

  • The Parametric Equity Premium Income ETF share price today is $26.26
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PAPI is experiencing slight selling pressure.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals, Inc.'s stock price today?

  • The Rhythm Pharmaceuticals, Inc. share price today is $113.56
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.

PAPI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.15 Buy
Relative Strength Index (14 RSI): 61.34 Buy
Chaikin Money Flow: -8761 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.58 - 26.1) Buy
Bollinger Bands (100): (25.49 - 26.15) Buy

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.67 Buy
Relative Strength Index (14 RSI): 59.45 Buy
Chaikin Money Flow: -357754 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (98.81 - 108.61) Buy
Bollinger Bands (100): (93.91 - 107.83) Buy

PAPI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 26.05 Buy
20-day SMA: 25.86 Buy
50-day SMA: 25.77 Buy
200-day SMA: 25.74 Buy
8-day EMA: 26.09 Buy
20-day EMA: 25.93 Buy
50-day EMA: 25.28 Buy
200-day EMA: 15.93 Buy

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 107.1 Buy
20-day SMA: 105.06 Buy
50-day SMA: 105.14 Buy
200-day SMA: 81.74 Buy
8-day EMA: 108.55 Buy
20-day EMA: 106.16 Buy
50-day EMA: 103.93 Buy
200-day EMA: 86.65 Buy

Parametric Equity Premium Income ETF Earnings Growth & PAPI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.56 per share.

Parametric Equity Premium Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):